Atlas Trials

Valganciclovir to Reduce T Cell Activation in HIV Infection

Clinical trial NCT00264290 · COMPLETED

Trial details

NCT number
NCT00264290
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HIV InfectionsCytomegalovirus Infections
Start date
2006-08-01
Primary completion
2008-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.